NeisVac-CTM

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Haemophilus Influenzae Type bInfections, MeningococcalMeningococcal VaccinesNeisseria Meningitidis

Phase 3

Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines

CompletedNCT00891176

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2009-05-14End: 2012-11-21Updated: 2018-02-15

Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines

CompletedNCT01144663

GlaxoSmithKlineInfections, Meningococcal, Meningococcal Vaccines

Start: 2010-07-01End: 2013-09-10Updated: 2020-12-31

Related Papers

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized Trial.

2018-07-011 citations

Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.

2017-04-0110 citations

Antibody persistence and immunologic memory in children vaccinated with 4 doses of pneumococcal conjugate vaccines: Results from 2 long-term follow-up studies

Human Vaccines & Immunotherapeutics2016-10-137 citations

Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines

Clinical and Vaccine Immunology2016-05-05